HERON THERAPEUTICS, INC. /DE/ (HRTX) Current Ratio % [USD] 2012 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Heron Therapeutics, Inc. /De/ quarterly Current Ratio history and growth rate from 2012 to 2024.
  • Heron Therapeutics, Inc. /De/ Current Ratio for the quarter ending March 31, 2024 was 228 %, a 3.55% increase year-over-year.
Current Ratio, Quarterly (% [USD])
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 228 +7.82 +3.55% Mar 31, 2024
Q4 2023 224 +0.71 +0.32% Dec 31, 2023
Q3 2023 227 -16.2 -6.66% Sep 30, 2023
Q2 2023 227 -58.5 -20.5% Jun 30, 2023
Q1 2023 220 -143 -39.4% Mar 31, 2023
Q4 2022 223 -147 -39.7% Dec 31, 2022
Q3 2022 244 -111 -31.3% Sep 30, 2022
Q2 2022 285 -55.3 -16.2% Jun 30, 2022
Q1 2022 364 +25.9 +7.66% Mar 31, 2022
Q4 2021 370 -14 -3.63% Dec 31, 2021
Q3 2021 354 -78.6 -18.1% Sep 30, 2021
Q2 2021 340 -97 -22.2% Jun 30, 2021
Q1 2021 338 -93.6 -21.7% Mar 31, 2021
Q4 2020 384 -43.9 -10.3% Dec 31, 2020
Q3 2020 433 +7.96 +1.87% Sep 30, 2020
Q2 2020 437 -56 -11.3% Jun 30, 2020
Q1 2020 432 -124 -22.3% Mar 31, 2020
Q4 2019 428 -58.6 -12% Dec 31, 2019
Q3 2019 425 +19.4 +4.79% Sep 30, 2019
Q2 2019 493 +181 +57.8% Jun 30, 2019
Q1 2019 555 +334 +151% Mar 31, 2019
Q4 2018 487 +214 +78.3% Dec 31, 2018
Q3 2018 406 +127 +45.6% Sep 30, 2018
Q2 2018 313 +6.23 +2.03% Jun 30, 2018
Q1 2018 221 -90.9 -29.2% Mar 31, 2018
Q4 2017 273 -23 -7.77% Dec 31, 2017
Q3 2017 279 -149 -34.9% Sep 30, 2017
Q2 2017 306 -269 -46.8% Jun 30, 2017
Q1 2017 312 -482 -60.7% Mar 31, 2017
Q4 2016 296 -511 -63.3% Dec 31, 2016
Q3 2016 428 -359 -45.6% Sep 30, 2016
Q2 2016 576 -164 -22.2% Jun 30, 2016
Q1 2016 794 +107 +15.6% Mar 31, 2016
Q4 2015 807 +44.8 +5.88% Dec 31, 2015
Q3 2015 787 -112 -12.4% Sep 30, 2015
Q2 2015 740 -113 -13.3% Jun 30, 2015
Q1 2015 687 +38 +5.85% Mar 31, 2015
Q4 2014 762 +164 +27.3% Dec 31, 2014
Q3 2014 899 +307 +51.9% Sep 30, 2014
Q2 2014 853 +87.4 +11.4% Jun 30, 2014
Q1 2014 649 -260 -28.6% Mar 31, 2014
Q4 2013 599 -351 -37% Dec 31, 2013
Q3 2013 592 -139 -19.1% Sep 30, 2013
Q2 2013 765 +244 +46.7% Jun 30, 2013
Q1 2013 909 +322 +54.8% Mar 31, 2013
Q4 2012 950 Dec 31, 2012
Q3 2012 731 Sep 30, 2012
Q2 2012 522 Jun 30, 2012
Q1 2012 587 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.